Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Characterization of error profile in three next generation sequencing platforms

PROVIDER: PRJNA1277372 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33996723_1.fastq.gz	Fastqsanger.gz
	SRR33996723_2.fastq.gz	Fastqsanger.gz
	SRR33996724_1.fastq.gz	Fastqsanger.gz
	SRR33996724_2.fastq.gz	Fastqsanger.gz
	SRR33996725_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [NanoString]

2015-05-03 | GSE62017 | GEO

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [microarray]

2015-05-03 | GSE62011 | GEO

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [sequencing]

2015-05-03 | GSE62010 | GEO

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [sequencing]

Project description:This work highlights similarities and differences between three platforms (next-generation sequencing, microarray and NanoString) for detecting miRNAs and compares their strengths and weaknesses. miRNA expression profiles were determined in 6 Hepatoblastoma FFPE samples using a next-generation sequencing platform.

2015-05-03 | E-GEOD-62010 | biostudies-arrayexpress

DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing

Project description:DNA copy number variations occur within populations and aberrations can cause disease. We sought to develop an improved lab-automatable, cost-efficient, accurate platform to profile DNA copy number. We developed a sequencing-based assay of nuclear, mitochondrial, and telomeric DNA copy number that draws on the unbiased nature of next-generation sequencing and incorporates techniques developed for RNA expression profiling. To demonstrate this platform, we assayed UMC-11 cells using 5 million 33 nt reads and found tremendous copy number variation, including regions of single and homogeneous deletions and amplifications to 29 copies; 5 times more mitochondria and 4 times less telomeric sequence than a pool of non-diseased, blood-derived DNA; and that UMC-11 was derived from a male individual. The described assay outputs absolute copy number, outputs an error estimate (p-value), and is more accurate than array-based platforms at high copy number. The platform enables profiling of mitochondrial levels and telomeric length. The assay is lab-automatable and has a genomic resolution and cost that are tunable based on the number of sequence reads. DNA genome sequencing at roughly 0.03 coverage to identify genomic copy number variations

2010-04-02 | E-GEOD-21159 | biostudies-arrayexpress

Microbiome characterization of the Pasto River using next-generation sequencing platforms.

Project description:Microbiome characterization of the Pasto River using next-generation sequencing platforms

| PRJEB64340 | ENA

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [NanoString]

Project description:This work highlights similarities and differences between three platforms (next-generation sequencing, microarray and NanoString) for detecting miRNAs and compares their strengths and weaknesses. miRNA expression profiles were determined in Hepatoblastoma FFPE samples using a NanoString platform.

2015-05-03 | E-GEOD-62017 | biostudies-arrayexpress

A cross-comparison of technologies for the detection of microRNAs from FFPE samples of hepatoblastoma patients [microarray]

2015-05-03 | E-GEOD-62011 | biostudies-arrayexpress

mouse_APAP

Project description:Comprehensive cataloging of cell-free circulating RNAs using next generation sequencing technology may open a window to assess drug associated adverse effects at the systems level. To explore this potential, we conducted an RNA profiling study using the well-characterized acetaminophen overdose mouse model on liver and plasma with next generation sequencing platforms.

2013-03-08 | E-MTAB-1538 | biostudies-arrayexpress

EGFRvIII/STAT3 targets in glioblastoma pathogenesis

Project description:Next generation sequencing platforms were used to identify STAT3 targets in the background of EGFRvIII expresssion

2016-04-13 | GSE51281 | GEO